Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)
A pharmaceutical company dedicated to the discovery, development and commercialization of therapies to treat patients with cancer.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
2win
(< 20)
Submitted: 5/13/2013 7:53:03 AM :
Start Price:
$5.51
ASTX Score:
-4.01
AB bullish engulfing
Recs
NoblyNaive
(84.82)
Submitted: 4/26/2013 1:07:44 PM :
Start Price:
$6.55
ASTX Score:
-22.72
Despicable P/E ratio, but pitches by Cramer on other biotechnology firms has led me to discount this a bit. EPS and revenue growths are impressive. So is the stock price action.
April 26: As of about April 15, 2013, I became long ASTX (with real mony, no less), and still am long.
Recs
Recs
reachmygoals1
(< 20)
Submitted: 9/14/2012 9:58:09 AM :
Start Price:
$4.07
ASTX Score:
+25.74
going up immediately, will surge when expected eu approval for AML on Dacogen by end of September. stay tuned
Recs
SamsaricSufferer
(< 20)
Submitted: 4/7/2012 3:43:23 PM :
Start Price:
$1.80
ASTX Score:
+177.95
A wonder in their industry. A biotech with actual revenues and a deep pipeline.
Recs
Imhilion
(68.87)
Submitted: 2/12/2012 8:42:23 PM :
Start Price:
$2.06
ASTX Score:
+138.03
Technical Indicators!
Recs
BuffettJunior1
(98.12)
Submitted: 2/7/2012 7:19:53 PM :
Start Price:
$2.27
ASTX Score:
+113.55
Cheap biotech with huge potential.
Recs
Teknowizz
(97.65)
Submitted: 2/3/2012 2:29:45 PM :
Start Price:
$2.88
ASTX Score:
+63.15
FDA Advisory Committee on Feb 9th; if positive approval in March is likely. Has already risen a lot, but still....
Recs
seattle1218
(< 20)
Submitted: 1/27/2012 6:05:11 PM :
Start Price:
$2.66
ASTX Score:
+74.84
Several drugs in the pipeline, will rise in value at least until it reaches the point of fda approval which is March 9, 1012. I may sell before that day.
Recs
portefeuille
(99.75)
Submitted: 12/15/2011 9:34:31 PM :
Start Price:
$1.87
ASTX Score:
+148.26
There are currently 2500 ASTX shares in my "fund" with break-even of around 0.53 USD.
http://caps.fool.com/Blogs/fund-trades/678775.
Recs
niggyt
(36.50)
Submitted: 4/20/2011 3:48:59 PM :
Start Price:
$2.64
ASTX Score:
+78.84
They have cash.
Recs
rocknpopstocks
(< 20)
Submitted: 1/21/2011 2:56:52 PM :
Start Price:
$2.93
ASTX Score:
+54.40
SuperGen is due.
Recs
21popsontop
(< 20)
Submitted: 11/12/2010 12:00:53 PM :
Start Price:
$2.69
ASTX Score:
+61.89
Drugs and longshots that could get super real.
Recs
RickyMojo
(< 20)
Submitted: 4/8/2010 11:40:36 PM :
Start Price:
$3.20
ASTX Score:
+28.61
Cure for cancer?
Recs
zackmax
(35.72)
Submitted: 3/11/2010 3:41:14 PM :
Start Price:
$3.25
ASTX Score:
+21.57
ccest compte
Recs
craigt101
(84.72)
Submitted: 11/25/2009 5:40:11 PM :
Start Price:
$2.74
ASTX Score:
+46.80
Well heeled, financially...a comfortable moat...provides lots of room for R&D without feeling the pinch. Management appears to have built and strong model for developing cancer and related therapies that cover a broad spectrum of life-threatening diseases. I originally bought in at $2.22 and will give it several years. Who knows...maybe a buyout is down the line, as well.
Recs
libertybrewcity
(< 20)
Submitted: 11/2/2009 5:13:10 PM :
Start Price:
$2.37
ASTX Score:
+66.81
lots of cash, pipeline with good potential
Recs
topsecret10
(< 20)
Submitted: 10/13/2009 6:32:30 PM :
Start Price:
$2.56
ASTX Score:
+57.33
Lots of Insider buying here..... SuperGen is a pharmaceutical company whose mission is to prolong, improve the quality of and ultimately, save the lives of those people afflicted with life-threatening diseases, especially cancer.
The company possesses a broad portfolio of proprietary cancer therapies that target a variety of solid tumors, hematological malignancies and blood disorders, offering renewed hope to patients who suffer from these illnesses.
The company is led by a seasoned management team with extensive experience in all aspects of the oncology pharmaceutical industry. TS
Recs
ramgee1
(< 20)
Submitted: 7/29/2009 5:01:50 AM :
Start Price:
$2.75
ASTX Score:
+24.44
They have significant cash and cash flow to enable the development of their pipeline of drug candidates. They are a significant buyout possibility.
Recs
realworld2
(< 20)
Submitted: 7/24/2009 11:56:52 PM :
Start Price:
$2.88
ASTX Score:
+15.52
great pipeline. bought at 2.01 with real money
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 36 : 1 2 Next »